Intelligent Bio Solutions (NASDAQ:INBS) Shares Down 0.6% – Here’s Why

Intelligent Bio Solutions Inc. (NASDAQ:INBS) shares traded down 0.6% during mid-day trading on Wednesday . The company traded as low as $1.58 and last traded at $1.64. 53,755 shares were traded during mid-day trading, a decline of 96% from the average session volume of 1,367,589 shares. The stock had previously closed at $1.65.

Intelligent Bio Solutions Stock Down 2.6 %

The business’s fifty day moving average is $1.55 and its 200-day moving average is $1.64.

Intelligent Bio Solutions (NASDAQ:INBS) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.70) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.53) by ($0.17). The business had revenue of $872.29 million during the quarter. Intelligent Bio Solutions had a negative return on equity of 147.50% and a negative net margin of 288.35%. As a group, analysts expect that Intelligent Bio Solutions Inc. will post -1.25 EPS for the current year.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.